sons, and covered horseraces consistent with the pro-
visions of this Act. 
(2) POWERS.—The Authority shall be vested 
with the same anti-doping and medication control 
powers over horseracing licensees as the State racing 
commissions have in their respective States in re-
spect to access to offices, track facilities, and other 
places of business of licensees, search and seizure, 
issuance and enforcement of subpoenas and sub-
poenas duces tecum, and other investigatory powers. 
(3) CONSENT.—As a condition of eligibility to 
participate in covered horseraces, covered persons 
agree that they and their covered horses shall be 
bound by the provisions of the horseracing anti- 
doping and medication control program established 
in accordance with section 6. 
(c) EXCLUSIVE JURISDICTION AND OVERSIGHT.— 
(1) JURISDICTION OF COMMISSION.—The Com-
mission shall have exclusive jurisdiction over all 
horseracing anti-doping and medication control mat-
ters consistent with this Act. 
(2) ACTIVITIES OF AUTHORITY.—The Authority 
shall engage in activities in accordance with such 
rules as are approved pursuant to this Act. 
VerDate Sep 11 2014 
23:36 Apr 03, 2019
Jkt 089200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H1754.IH
H1754
pamtmann on DSKBFK8HB2PROD with BILLS
(d) GUIDING PRINCIPLES.—In carrying out the pro-
visions of this Act, the Commission and the Authority 
shall be guided by the findings and principles contained 
in section 2. 
(e) STATE COMPACT.—The jurisdiction and authority 
granted to the Commission and the Authority under this 
Act shall terminate if, at any time after the expiration of 
five years following the effectiveness of the anti-doping 
and medication control program— 
(1) an interstate compact is established that in-
cludes among its members 75 percent of the States 
in which starts in covered races occurred during the 
calendar year preceding the formation of the com-
pact and those States which collectively hosted not 
less than 90 percent of the total racing starts of cov-
ered horses in covered races for the two-year period 
preceding the formation of the compact; and 
(2)(A) all member States enter into and main-
tain an agreement with the Authority for services 
consistent with the anti-doping and medication con-
trol program provided for in section 6 in those 
States; or 
(B) the compact is drafted with public input 
from horseracing industry constituencies (including 
trainers, owners, the breed registry, veterinarians, 
VerDate Sep 11 2014 
23:36 Apr 03, 2019
Jkt 089200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H1754.IH
H1754
pamtmann on DSKBFK8HB2PROD with BILLS
regulators, race tracks, testing laboratories, bettors, 
and jockeys) by persons who conform to the conflict 
of interest restrictions set forth in section 5(d); obli-
gates the compact to pay the costs of winding down 
the Authority and transitioning its operations to the 
compact; provides for uniform anti-doping and medi-
cation control regulations among all member States, 
consistent with section 6 and no less restrictive than 
the Authority’s most recent anti-doping and medica-
tion control program; and is governed and main-
tained by a board, which would include among its 
members persons meeting the requirements of sec-
tion 5(b), each board member conforming to the 
conflict of interest restrictions set forth in section 
5(d). 
The consent of Congress is hereby given to interstate com-
pacts meeting the requirements referenced in this section 
5(h). 
SEC. 5. ESTABLISHMENT OF HORSERACING ANTI-DOPING 
AND MEDICATION CONTROL AUTHORITY. 
(a) ESTABLISHMENT.—There is established the 
Horseracing Anti-doping and Medication Control Author-
ity, a private, independent, self-regulatory, nonprofit cor-
poration with responsibility for developing and admin-
istering an anti-doping and medication control program 
VerDate Sep 11 2014 
23:36 Apr 03, 2019
Jkt 089200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H1754.IH
H1754
pamtmann on DSKBFK8HB2PROD with BILLS
for covered horses, covered persons, and covered 
horseraces. 
(b) COMPOSITION.—The Authority shall be governed 
by a board (in this section referred to as the ‘‘Board’’) 
which shall be comprised of the following: 
(1) The chief executive officer of the United 
States Anti-Doping Agency. 
(2) Six individuals, selected by the United 
States Anti-Doping Agency from among members of 
the board of the United States Anti-Doping Agency. 
(3) Six individuals selected by the United 
States Anti-Doping Agency— 
(A) from among individuals who represent 
different equine industry constituencies; and 
(B) such that— 
(i) at least 1 member has expertise in 
equine anti-doping and medication control 
regulation; 
(ii) at least 1 member has significant 
experience as an owner of covered horses 
or is a person with expertise in the breed-
ing of race horses; 
(iii) at least 1 member was formerly 
employed as an executive with a racetrack; 
VerDate Sep 11 2014 
23:36 Apr 03, 2019
Jkt 089200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H1754.IH
H1754
pamtmann on DSKBFK8HB2PROD with BILLS
(iv) at least 1 member has a degree in 
veterinary medicine and either has exper-
tise in equine veterinary practice with re-
gard to race horses or expertise in veteri-
nary research in matters affecting race 
horses; 
(v) at least 1 member has expertise in 
training covered horses; and 
(vi) at least 1 member has expertise 
in riding covered horses as a jockey. 
(c) SELECTION METHODOLOGY.—In selecting indi-
viduals under subsection (b), the United States Anti- 
Doping Agency shall— 
(1) solicit lists of 2 candidates each from a 
cross-section of equine industry representatives; 
(2) endeavor to provide diversity among the 
Board’s membership between persons primarily in-
volved with the 3 breeds of racehorses, to the great-
est extent practicable and consistent with the stand-
ards for Board membership set forth in this section; 
(3) if Board positions remain unfilled from the 
lists solicited under paragraph (1), ask organiza-
tions, groups, and associations that represent the 
various equine constituencies set forth in subsection 
(b)(3)(B) to submit an additional 2 candidates from 
VerDate Sep 11 2014 
23:36 Apr 03, 2019
Jkt 089200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H1754.IH
H1754
pamtmann on DSKBFK8HB2PROD with BILLS